# Regeneron Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 25, 2024

- Company: [Regeneron Pharmaceuticals, Inc.](/companies/regn.md) (CIK 872589)
- Form: DEF 14A
- Filed: 2024-04-25
- Accepted by EDGAR: Apr 25, 2024, 16:01 ET
- Period: 2024-06-14
- Accession: 0001308179-24-000577
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/872589/000130817924000577/lregn2024_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/872589/000130817924000577/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/872589/000130817924000577/lregn2024_def14a.htm

Filed Apr 25, 2024.
Source: SEC EDGAR, the filing index for accession 0001308179-24-000577. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.